Shorted
Amplia Therapeutics logo
ATX

Amplia Therapeutics

Pharmaceuticals, Biotechnology & Life Sciences

Amplia Therapeutics Limited focuses on developing therapies targeting focal adhesion kinase (FAK) inhibitors for the treatment of cancer and fibrosis. The company is positioned within the biotechnology sector, leveraging advanced scientific research to develop clinical candidates aimed at unmet medical needs, potentially offering transformative therapies in oncology and fibrotic diseases.

Short position

short percentage0.01%
reported shorts30.1K
shares on issue513.312M

Amplia Therapeutics (ASX:ATX) has 0.01% of its shares on issue reported as short positions as of 5 Oct 2026, or about 30,144 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.23% in November 2024. ATX is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Amplia Therapeutics (ATX) short interest history

ATX Short Interest History

30-day change
0.00pp
90-day change
-0.01pp
1-year change
-0.01pp
All-time high
0.23% (November 2024)
All-time low
0.00% (July 2025)

Is ATX heavily shorted?

Not especially: 0.01% short interest is modest by ASX standards, ranking #612 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.

How has ATX's short interest changed recently?

Over the past 30 days Amplia Therapeutics's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.01% of shares on issue.

What is the highest ATX's short interest has been?

Since 2018, Amplia Therapeutics's short interest peaked at 0.23% in November 2024 and bottomed at 0.00% in July 2025.

Where does this data come from?

All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2018. See our methodology.